Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportCardiovascular: Basic Science

Preparation and evaluation of a 99mTc-labeled rhodamine-conjugated angiotensin peptide as a cardiac function imaging agent

Subhani Okarvi
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1093;
Subhani Okarvi
1Cyclotron and Radiopharmaceuticals, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1093

Objectives Angiotensin II (Ang II) is an octapeptide that has been known to play an important role in cardiovascular function. In an attempt to develop a SPECT-based cardiac agent with enhanced targeting efficiency, we linked Ang II to rhodamine (Rh), a lipophilic cation (like 99mTc-MIBI), that specifically accumulates in the myocardium. The Rh conjugated Ang II was evaluated for its potential as a heart imaging agent.

Methods Rh-Lys-Gly-Cys-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-CONH2 was prepared by solid-phase peptide synthesis following the Fmoc/HBTU chemistry. NHS-Rh was attached to the peptide via the free amino group of Lys residue by manual synthesis. Rh-Ang II conjugate was radiolabeled with Tc-99m by the stannous-tartrate exchange labeling method. In vitro stability was determined in human plasma and in excess cysteine and histidine. In vivo biodistribution/pharmacokinetics was performed in Balb/c mice and Sprague Dawley rats.

Results The bioconjugate radiolabeled efficiently with Tc-99m (>75%) as determined by HPLC. Tc-99m-Rh-Ang II exhibited stability in vitro as follows: His>Cys>plasma. In mice, the radioconjugate displayed efficient clearance from the blood and excreted mainly through the renal route with some elimination by the hepatobiliary pathway. The uptake in the heart was 1.79±0.51% ID/g as early as 30 min p.i. whereas, accumulation of radioactivity in the lungs, liver, stomach and kidneys varied between 1 to 10% ID/g). In rats, the hybrid conjugate showed better pharmacokinetic characteristics with low uptake in the major organs/tissues (<4.0% ID/g). The uptake in the heart, 1.70±0.42% ID/g, was found to be higher than in the blood and muscle resulting in good heart-to-blood and heart-to-muscle ratios.

Conclusions Our preliminary findings suggest that the use of hybrid conjugate appears to hold promise as a new and attractive approach for rapid and efficient diagnostic imaging of heart

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preparation and evaluation of a 99mTc-labeled rhodamine-conjugated angiotensin peptide as a cardiac function imaging agent
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preparation and evaluation of a 99mTc-labeled rhodamine-conjugated angiotensin peptide as a cardiac function imaging agent
Subhani Okarvi
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1093;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preparation and evaluation of a 99mTc-labeled rhodamine-conjugated angiotensin peptide as a cardiac function imaging agent
Subhani Okarvi
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1093;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Cardiovascular: Basic Science

  • The performance of phase analysis in the presence of perfusion defects
  • Roles of cardiac norepinephrine uptake 1 and 2 in evaluation of LMI1195, a new cardiac PET neuronal imaging agent, in rats, rabbits and nonhuman primates
Show more Cardiovascular: Basic Science

Basic Science Posters (Cardiovascular)

  • Feasibility and characteristics of Ga-68-RGD PET for myocardial infarction imaging
  • Comparison of uptake of CardioPET, a potential PET tracer for myocardial fatty acid utilization and BFPET, a possible PET blood flow marker in fed vs fasted mice
Show more Basic Science Posters (Cardiovascular)

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire